129 related articles for article (PubMed ID: 30055381)
21. Semiquantitative analysis using standardized uptake value in
Toriihara A; Daisaki H; Yamaguchi A; Kobayashi M; Furukawa S; Yoshida K; Isogai J; Tateishi U
Clin Imaging; 2018; 52():57-61. PubMed ID: 29909364
[TBL] [Abstract][Full Text] [Related]
22. The role of DAT-SPECT in movement disorders.
Kägi G; Bhatia KP; Tolosa E
J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):5-12. PubMed ID: 20019219
[TBL] [Abstract][Full Text] [Related]
23. "Parkinson-dementia" diseases: a comparison by double tracer SPECT studies.
Rossi C; Volterrani D; Nicoletti V; Manca G; Frosini D; Kiferle L; Unti E; De Feo P; Bonuccelli U; Ceravolo R
Parkinsonism Relat Disord; 2009 Dec; 15(10):762-6. PubMed ID: 19553153
[TBL] [Abstract][Full Text] [Related]
24. Degenerative parkinsonism in patients with psychogenic parkinsonism: A dopamine transporter imaging study.
Felicio AC; Godeiro-Junior C; Moriyama TS; Shih MC; Hoexter MQ; Borges V; Silva SM; Aguiar Pde C; Andrade LA; Bressan RA; Ferraz HB
Clin Neurol Neurosurg; 2010 May; 112(4):282-5. PubMed ID: 20061077
[TBL] [Abstract][Full Text] [Related]
25. Imaging the dopaminergic system in suspected parkinsonism, drug induced movement disorders, and Lewy body dementia.
Kemp PM
Nucl Med Commun; 2005 Feb; 26(2):87-96. PubMed ID: 15657499
[TBL] [Abstract][Full Text] [Related]
26. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
[TBL] [Abstract][Full Text] [Related]
27. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
Klein JC; Eggers C; Kalbe E; Weisenbach S; Hohmann C; Vollmar S; Baudrexel S; Diederich NJ; Heiss WD; Hilker R
Neurology; 2010 Mar; 74(11):885-92. PubMed ID: 20181924
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
Morgan S; Kemp P; Booij J; Costa DC; Padayachee S; Lee L; Barber C; Carter J; Walker Z
J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1063-70. PubMed ID: 22869921
[TBL] [Abstract][Full Text] [Related]
29. [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies.
van der Zande JJ; Booij J; Scheltens P; Raijmakers PG; Lemstra AW
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1060-6. PubMed ID: 26830298
[TBL] [Abstract][Full Text] [Related]
30. Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study.
Ceravolo R; Volterrani D; Gambaccini G; Bernardini S; Rossi C; Logi C; Tognoni G; Manca G; Mariani G; Bonuccelli U; Murri L
J Neural Transm (Vienna); 2004 Aug; 111(8):1065-73. PubMed ID: 15254794
[TBL] [Abstract][Full Text] [Related]
31. Using striatal dopamine transporter single photon emission computed tomography imaging to rule out Dementia with Lewy Bodies in elderly patients with antipsychotic-induced parkinsonism.
Schuster JP; Buhl C; Archambaud F; Hardy P; Chouinard G; Prigent A; Corruble E
Psychiatry Clin Neurosci; 2007 Apr; 61(2):206. PubMed ID: 17362445
[No Abstract] [Full Text] [Related]
32. Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging.
Marshall VL; Patterson J; Hadley DM; Grosset KA; Grosset DG
Nucl Med Commun; 2006 Dec; 27(12):933-7. PubMed ID: 17088677
[TBL] [Abstract][Full Text] [Related]
33. Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update.
Tatsch K; Poepperl G
J Nucl Med; 2013 Aug; 54(8):1331-8. PubMed ID: 23864718
[TBL] [Abstract][Full Text] [Related]
34. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations.
Benamer HT; Oertel WH; Patterson J; Hadley DM; Pogarell O; Höffken H; Gerstner A; Grosset DG
Mov Disord; 2003 Sep; 18(9):977-84. PubMed ID: 14502664
[TBL] [Abstract][Full Text] [Related]
35. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.
Iranzo A; Santamaría J; Valldeoriola F; Serradell M; Salamero M; Gaig C; Niñerola-Baizán A; Sánchez-Valle R; Lladó A; De Marzi R; Stefani A; Seppi K; Pavia J; Högl B; Poewe W; Tolosa E; Lomeña F
Ann Neurol; 2017 Sep; 82(3):419-428. PubMed ID: 28833467
[TBL] [Abstract][Full Text] [Related]
36. Functional imaging in Parkinson's disease and dementia with Lewy bodies.
Colloby S; O'Brien J
J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):158-63. PubMed ID: 15312279
[TBL] [Abstract][Full Text] [Related]
37. In vivo dopamine pre-synaptic receptors and antioxidant activities in patients with Alzheimer's disease, dementia with Lewy bodies and in controls. A preliminary report.
Tabet N; Walker Z; Mantle D; Costa D; Orrell M
Dement Geriatr Cogn Disord; 2003; 16(1):46-51. PubMed ID: 12714800
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study.
Kamagata K; Nakatsuka T; Sakakibara R; Tsuyusaki Y; Takamura T; Sato K; Suzuki M; Hori M; Kumamaru KK; Inaoka T; Aoki S; Terada H
Neuroradiology; 2017 Jan; 59(1):89-98. PubMed ID: 28035426
[TBL] [Abstract][Full Text] [Related]
39. Update on SPECT and PET in parkinsonism - part 1: imaging for differential diagnosis.
Meyer PT; Hellwig S
Curr Opin Neurol; 2014 Aug; 27(4):390-7. PubMed ID: 24950013
[TBL] [Abstract][Full Text] [Related]
40. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.
Van Laere K; Casteels C; De Ceuninck L; Vanbilloen B; Maes A; Mortelmans L; Vandenberghe W; Verbruggen A; Dom R
J Nucl Med; 2006 Mar; 47(3):384-92. PubMed ID: 16513606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
